Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Veronique Edeline"'
Publikováno v:
Médecine Nucléaire. 45:59-69
Resume L’immunotherapie avec les inhibiteurs de points de controle immunitaire est devenue le traitement de reference dans certains types tumoraux, tels que le melanome et le cancer bronchique non a petites cellules. Contrairement aux therapies con
Autor:
M. Bertaux, Caroline Houillier, Sébastien Bergeret, Khê Hoang-Xuan, Veronique Edeline, Valérie Touitou, Sylvain Choquet, Nathalie Cassoux, Alain Giron, Aurélie Kas, Marie-Odile Habert, Carole Soussain, Karima Mokhtari
Publikováno v:
Journal of neuro-oncology. 148(2)
Primary Central Nervous System Lymphoma (PCNSL) is a rare disease with different therapeutic implications than systemic lymphoma. In this study, we evaluated whole-body 18FDG-PET/CT for pre-chemotherapy imaging of suspected PCNSL. One hundred and thi
Publikováno v:
Cancer/Radiothérapie. 22:384-392
It is now well demonstrated that (18F)-fluorodeoxyglucose PET/CT is the most accurate imaging method for determining disease extent in Hodgkin lymphoma. Thus, up-front PET/CT is mandatory for involved node radiation therapy design. For a proper use o
Autor:
Thomas Gastinne, Julien Lazarovici, Veronique Edeline, Alexandra Traverse-Glehen, Anne Corby, Lysiane Molina, Nawel Belmecheri, Krimo Bouabdallah, Sandy Amorim, Diane Damotte, David Sibon, Rene-Olivier Casasnovas, Vincent Ribrag, Emmanuelle Nicolas-Virelizier, Franck Morschhauser, Alina Berriolo-Riedinger, Thierry Vander Borght, Anne-Claire Gac, Bohrane Slama, Eric Durot, Stéphanie Guidez, Vincent Launay, Pierre Feugier, Kamel Laribi, Marc André
Publikováno v:
Blood. 138:232-232
Background In contrast to the high cure rates in young patients (pts) treated with anthracycline-based chemotherapy, classical Hodgkin lymphoma (cHL) prognosis is poor in elderly pts, and very few data exist for pts considered too frail to receive st
Autor:
Julien Lazarovici, Ilan Tal, Thomas Gastinne, Aspasia Stamatoullas-Bastard, Rene-Olivier Casasnovas, Salim Kanoun, Reda Bouabdallah, Hervé Ghesquières, Samuel Griolet, Veronique Edeline, Pauline Brice, Anne-Ségolène Cottereau, Cédric Rossi, Michel Meignan, Alina Berriolo-Riedinger, Jehan Dupuis, Marc André
Publikováno v:
Blood. 138:880-880
Background: The AHL2011 study demonstrated that a PET-driven strategy allows to deescalate treatment to 4 x ABVD in PET negative patients after 2 cycles of escalated BEACOPP (BEACOPPesc) without loss of tumor control in patients with advanced Hodgkin
Autor:
Jehan Dupuis, Veronique Edeline, Aspasia Stamatoulas Bastard, Clementine Joubert, Anne Claire Gac, Herve Ghesquieres, Julien Lazarovici, Emmanuelle Nicolas-Virelizier, Bertrand Joly, Reda Bouabdallah, Alina Berriolo-Riedinger, Pauline Brice, Julie Dechene, Krimo Bouabdallah, Marc André, Michel Meignan, Judith Racapé, P. Feugier, Franck Morschhauser, Isabelle Demeestere, Olivier Casasnovas, Thomas Gastinne
Publikováno v:
Blood, 136 (Supplement 1
Background AHL2011 study (NCT01358747) demonstrated that PET negativity after 2 cycles of upfront BEACOPPescalated (BEA) allows to switch to 4 cycles of ABVD 84% of patients (pts) with advanced Hodgkin lymphoma (HL) leading to reduce immediate treatm
Autor:
Richard Delarue, Emmanuelle Nicolas-Virelizier, Reda Bouabdallah, Veronique Edeline, Bertrand Joly, Adrian Tempescul, Hassan Farhat, Luc-Matthieu Fornecker, Peggy Dartigues, René-Olivier Casasnovas, Laurent Martin, Franck Morschhauser, Aspasia Stamatoullas, Pauline Brice, Marc André, Alain Delmer, Michel Meignan, Nicolas Mounier, Hervé Ghesquières, Jehan Dupuis, Philippe Quittet, Krimo Bouabdallah, Julien Lazarovici, Alina Berriolo-Riedinger, Anne-Claire Gac, Alexandra Traverse-Glehen, Pierre Feugier, Thierry Lamy, Thomas Gastinne, Hervé Maisonneuve
Publikováno v:
Lancet Oncology
Lancet Oncology, Elsevier, 2019
Lancet Oncology, Elsevier, 2019, 20 (2), pp.202-215. ⟨10.1016/S1470-2045(18)30784-8⟩
The Lancet. Oncology, Vol. 20, no. 2, p. 202-2015 (2019)
Lancet Oncology, 2019
Lancet Oncology, 2019, 20 (2), pp.202-215. ⟨10.1016/S1470-2045(18)30784-8⟩
Lancet Oncology, Elsevier, 2019
Lancet Oncology, Elsevier, 2019, 20 (2), pp.202-215. ⟨10.1016/S1470-2045(18)30784-8⟩
The Lancet. Oncology, Vol. 20, no. 2, p. 202-2015 (2019)
Lancet Oncology, 2019
Lancet Oncology, 2019, 20 (2), pp.202-215. ⟨10.1016/S1470-2045(18)30784-8⟩
International audience; Background: Increased-dose bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone (BEACOPPescalated) improves progression-free survival in patients with advanced Hodgkin lymphoma compare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::319a2829819df640946eb4a3996bc95e
https://hal.archives-ouvertes.fr/hal-01996114/document
https://hal.archives-ouvertes.fr/hal-01996114/document
Autor:
C. Houillier, M. Bertaux, Aurélie Kas, Carole Soussain, Marie-Odile Habert, Veronique Edeline, G. Bera, K.H. Xuan
Publikováno v:
Médecine Nucléaire. 40:103-113
Objectifs Le lymphome cerebral primitif (LCP) est une tumeur cerebrale rare correspondant a une proliferation lymphocytaire maligne limitee au systeme nerveux central. Le diagnostic est suspecte sur l’IRM cerebrale. Il est confirme par examen anato
Autor:
Veronique Edeline, Pauline Brice, Franck Morschhauser, Herv Ghesquieres, Vincent Ribrag, Lauriane Filliatre, Aspasia Stamatoullas, Philippe Quittet
Publikováno v:
Blood. 134:132-132
Introduction: About 10-15% of patients with localized and 25-30% with disseminated classical HL failed to respond or relapse after primary conventional treatment. For the youngest, autologous stem cell transplantation (ASCT) is a standard of care aft
Publikováno v:
Cancer Radiothérapie
Cancer Radiothérapie, Elsevier Masson, 2018, 22 (5), pp.393-400. ⟨10.1016/j.canrad.2018.06.001⟩
Cancer Radiothérapie, Elsevier Masson, 2018, 22 (5), pp.393-400. ⟨10.1016/j.canrad.2018.06.001⟩
IF 1.128; International audience; Fluorodeoxyglucose (FDG) positons emission tomography (PET)-computed tomography (CT) is used in many ways at baseline and during the treatment of patients with Hodgkin lymphoma. Many properties of the technique are u